ArticleOncology letters2017

Synergistic inhibitory effects of an engineered antibody-like molecule ATF-Fc and trastuzumab on tumor growth and invasion in a human breast cancer xenograft mouse model.

Hongwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.